Abuse Liability for Five Modern Oral Nicotine Products (NCT07132814)
An In-Clinic Confinement Study to Assess Elements of Abuse Liability for Five Modern Oral Nicotine Products
🩺 Plain-English Summary (8th-Grade Level)
This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers
Who can join: Review the eligibility criteria below.
Location: Dr. Vince Clinical Research — Overland Park, Kansas
Age range: 21 Years to 60 Years
🧪 Interventions in This Study
- Product A (OTHER)
- Product B (OTHER)
- Product C (OTHER)
- Product D (OTHER)
- Product E (OTHER)
- Product F (OTHER)
- Product N (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Dr. Vince Clinical Research — Overland Park, Kansas
📞 Contact the Study Coordinator
Phone: (336) 741-0386
Email: darnelj2@rjrt.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking
- Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) — Galveston, Texas
- Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study — Houston, Texas
- The Effect of Tobacco Products on Wound Healing — Minneapolis, Minnesota
- Digitally Enhanced Smoking Cessation for High Risk Smokers — Boston, Massachusetts
- Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava — Gainesville, Florida
- A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer — Basking Ridge, New Jersey
Explore by condition: All Smoking clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.